Call to Find Out if You Qualify: 866-439-6626 Understanding Clinical Trials
About the Study Drug
CP-690,550 is being developed as a potential disease-modifying anti-rheumatic drug delivered orally in pill form.
Am I a Trial Candidate?
CP-690,550 is being developed as a potential disease-modifying anti-rheumatic drug delivered orally in pill form.
Tell a Friend
Do you know someone with RA? Patients are being recruited now for the ORAL trials.
